2,2'-dipicolylamine has been researched along with Colitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; He, X; Huang, Z; Yang, HZ; Yu, XQ; Zhang, J; Zhao, RM | 1 |
1 other study(ies) available for 2,2'-dipicolylamine and Colitis
| Article | Year |
|---|---|
Zn-dipicolylamine-based reactive oxygen species-responsive lipids for siRNA delivery and in vivo colitis treatment.
Topics: Amines; Animals; Anti-Inflammatory Agents; Colitis; Lipids; Liposomes; Mice; Picolinic Acids; Reactive Oxygen Species; RNA, Messenger; RNA, Small Interfering; Tissue Distribution; Tumor Necrosis Factor-alpha; Zinc | 2022 |